Solmaz Sahebjam

Publication Activity (10 Years)

Years Active: 2023-2023
Publications (10 Years): 5

Top Topics

Locally Advanced

Positive Breast Cancer

Chemotherapy Induced

Top Venues

Neuro-oncology practice

NPJ breast cancer

Nature medicine

Clinical cancer research : an official journal of the American Association for Cancer Research

This page only lists publications with an associated author ORCID identifier.

Publications

Kirit Singh, Kelly M Hotchkiss, Ian F Parney, John De Groot, Solmaz Sahebjam, Nader Sanai, Michael Platten, Evanthia Galanis, Michael Lim, Patrick Y Wen, Giuseppe Minniti, Howard Colman, Timothy F Cloughesy, Minesh P Mehta, Marjolein Geurts, Isabel Arrillaga-Romany, Annick Desjardins, Kirk Tanner, Susan C Short, David Arons, Elizabeth Duke, Wolfgang Wick, Stephen J Bagley, David M Ashley, Priya Kumthekar, Roel G W Verhaak, Anthony J Chalmers, Anoop P Patel, Colin Watts, Peter E Fecci, Tracy T Batchelor, Michael Weller, Michael A Vogelbaum, Matthias Preusser, Mitchel S Berger, Mustafa Khasraw
Correcting the drug development paradigm for glioblastoma requires serial tissue sampling. Nature medicine (2023)
Solmaz Sahebjam, Heather Leeper
Towards gender equity in neuro-oncology. Neuro-oncology practice 11 (1) (2023)
Solmaz Sahebjam, Heather Leeper
Towards gender equity in neuro-oncology. Neuro-oncology practice 11 (1) (2023)
Nancy U Lin, Priya Kumthekar, Solmaz Sahebjam, Nuhad K Ibrahim, Anita Fung, Anna Cheng, Alan Nicholas, Jesse Sussell, Mark D Pegram
Pertuzumab plus high-dose trastuzumab for HER2-positive breast cancer with brain metastases: PATRICIA final efficacy data. NPJ breast cancer 9 (1) (2023)
Benedito Arruda Carneiro, Ludimila Cavalcante, Devalingam Mahalingam, Anwaar Saeed, Howard Safran, Wen Wee Ma, Andrew L Coveler, Steven Francis Powell, Bruno R Bastos, Elizabeth J Davis, Vaibhav Sahai, William Mikrut, James Longstreth, Sheri Smith, Taylor M Weiskittel, Hu Li, Brittany A Borden, Robert Donald Harvey, Solmaz Sahebjam, Andres Cervantes, Austin Koukol, Andrew P Mazar, Neeltje Steeghs, Razelle Kurzrock, Francis J Giles, Pamela N Munster
Phase 1 study of Elraglusib (9-ING-41), a glycogen synthase kinase-3b inhibitor, as monotherapy or combined with chemotherapy in patients with advanced malignancies. Clinical cancer research : an official journal of the American Association for Cancer Research (2023)